Cisapride-induced dysrhythmia in a pediatric patient receiving extracorporeal life support

Critical Care Medicine

Volumn 24, Issue 7, 1996, Pages 1268-1271

  Pettignano, Robert ^a,b   Chambliss, C Robert ^a   Darsey, Edress ^a   Heard, Michael ^a   Clark, Reese ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Children's Healthcare of Atlanta at Egleston   (United States)

Author keywords

cisapride; critical illness; dysrhythmia; extracorporeal life support; extracorporeal membrane oxygenation; pediatrics

Indexed keywords

CISAPRIDE;

ACETYLCHOLINE RELEASE; ARTICLE; CASE REPORT; CHILD; DRUG INDUCED DISEASE; EXTRACORPOREAL CIRCULATION; FEMALE; HEART ARRHYTHMIA; HUMAN; INTENSIVE CARE UNIT; INTESTINE MOTILITY; PRIORITY JOURNAL;

ARRHYTHMIA; CHILD; CISAPRIDE; EXTRACORPOREAL CIRCULATION; FEMALE; GASTROINTESTINAL MOTILITY; HUMANS; LIFE SUPPORT CARE; PIPERIDINES; SYMPATHOMIMETICS;

EID: 0029971028     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199607000-00035     Document Type: Article

References (17)

1. McCallum RW: Cisapride: A new class of prokinetic agent. Am J Gastroenterology 1991; 86:135-149
2. Schuurkes JAJ, Helsen LFM, Ghoos ECR, et al: Stimulation of gastroduodenal motor activity: Dopaminergic and cholinergic modulation. Drug Dev Res 1986; 8:233-241
3. McCallum RW, Prakash C, Campoli-Richards D, et al: Cisapride: A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders. Drugs 1988; 36:652-681
4. Spapen HD, Duinslaeger L, Diltoer M, et al: Gastric emptying in critically ill patients is accelerated by adding cisapride to a standard enterai feeding protocol: Results of a prospective, randomized, controlled trial. Crit Care Med 1995; 23:481-485
5. Rowbotham DJ, Nimmo WS: Effect of cisapride on morphine-induced delay in gastric emptying. Br J Anaesth 1987; 59:536-539
6. Olsson S, Edwards IR: Tachycardia during cisapride treatment. BMJ 1992; 305: 748-749
7. Bran S, Murray WA, Hirsch IB, et al: Long QT syndrome during high-dose cisapride. Arch Intern Med 1995; 155: 765-768
8. Muller-Lissner SA, the Bavarian Constipation Study Group: Treatment of chronic constipation with cisapride and placebo: Gut 1987; 28:1033-1038
9. Inman W, Kubota K: Tachycardia during cisapride treatment. BMJ 1992; 305:1019
10. Fehr HF: Risk factors, co-medication, and concomitant disease: Their influence on the outcome of therapy with cisapride. Scand J Gastroenterol 1993; 28(Suppl 195):40-46
11. Shaklai M, Pinkhas J, De Vries A: Metoclopramide and cardiac arrhythmias. BMJ 1974; ii:385
12. Bevacqua BK: Supraventricular tachycardia associated with postpartum metoclopramide administration. Anesthesiology 1988; 68:124-125
13. Humphrey PPA: Tachycardia during cisapride treatment. BMJ 1992; 305: 1019-1020
14. 4 receptors mediate arrhythmias? Trends in Pharmacologic Sciences 1994; 15: 451-445
15. 4 receptor mediating tachycardia in the pig. Br J Pharmacol 1991; 102:107-112
16. Kaumann AJ, Sanders L, Brown AM, et al: A 5-hydroxytryptamine receptor in human atrium. Br J Pharmacol 1990; 100:879-885
17. 4 receptor: A place in the sun. Trends Pharmacol Sci 1992; 13:141-145